Clinical Trial Update: Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluated preoperative Erlotinib (Tarceva) in patients with stages I/II non-small cell lung cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Carcinoma, Non-small Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2012-11-14